Related Experiment Videos

Adiponectin and chronic kidney disease

Fitsum Guebre-Egziabher1, Jocelyne Drai, Denis Fouque

  • 1Département de Néphrologie, Hôpital E. Herriot, Lyon, France.

Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
|January 3, 2007
PubMed

Insights

Chronic kidney disease (CKD) is linked to inflammation and insulin resistance. This review explores how adiponectin (ADP) levels change in CKD and their impact on cardiovascular health.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Chronic kidney disease (CKD) is associated with enhanced inflammation and reduced insulin sensitivity.
  • Cardiovascular disease (CVD) is a leading cause of mortality in end-stage renal disease (ESRD) patients.
  • Adiponectin (ADP) is an adipokine with anti-inflammatory and cardioprotective effects.

Purpose of the Study:

  • To review modifications of adiponectin (ADP) in chronic kidney disease (CKD).
  • To discuss factors influencing adiponectin (ADP) metabolism in renal failure.
  • To explore the association between ADP levels and cardiovascular outcomes in CKD patients.

Main Methods:

  • Literature review of studies examining adiponectin (ADP) in chronic kidney disease (CKD).
  • Analysis of factors affecting adiponectin (ADP) levels in renal failure.
  • Examination of the relationship between adiponectin (ADP) and cardiovascular outcomes.

Main Results:

  • Adiponectin (ADP) levels are paradoxically increased in various stages of chronic kidney disease (CKD), including end-stage renal disease (ESRD) patients on dialysis.
  • Despite elevated levels, adiponectin (ADP) function may be impaired in CKD.
  • Lower adiponectin (ADP) levels are correlated with adverse cardiovascular outcomes in CKD patients.

Conclusions:

  • Adiponectin (ADP) metabolism is significantly altered in chronic kidney disease (CKD).
  • The increased levels of adiponectin (ADP) in CKD do not appear to confer protection, and lower levels are linked to poor cardiovascular outcomes.
  • Further research is needed to understand the complex role of adiponectin (ADP) in CKD and its impact on cardiovascular health.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...